Table 1: Demographic data and IL-17 and IL-22 levels in the cerebrospinal fluid (CSF) and plasma of Guillain-Barré syndrome (GBS) patients and healthy controls (HC).

GBS (n = 22) HC (n = 18) Female/male 8/14 7/11 Age 41.91 ± 13.16 39.11 ± 11.18 White blood cells in CSF (per μL) 1.32 ± 1.21 1.06 ± 0.94 Total protein level in CSF (mg/dL) 71.56 ± 30.79* 52.01 ± 12.81 Albumin level in CSF (mg/dL) 49.58 ± 25.33** 30.27 ± 11.71 Albumin level in plasma (g/L) 41.55 ± 12.56 43.67 ± 14.66 Qalb × 100 1.24 ± 0.60* 0.79 ± 0.45 IL-17 concentration in CSF (pg/mL) 24.77 ± 7.45* 18.70 ± 8.72 IL-17 level in plasma (pg/mL) 17.39 ± 4.87* 13.35 ± 4.54 IL-22 concentration in CSF (pg/mL) 25.38 ± 12.35*** 8.19 ± 2.50 IL-22 level in plasma (pg/mL) 96.40 ± 52.28* 63.01 ± 27.22

Data are expressed as mean ± SD, student's t-test. *: Statistically significant in comparison with HC, *P < 0.05, **P < 0.01, ***P < 0.001. Qalb = CSF albumin/plasma albumin.